| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 7.9e-05 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -4.7e-05 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 4.5e-05 | 1 |